Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide
about
New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016).Chemical shift assignments of Ribosomal protein S1 from Mycobacterium tuberculosis.Pyrazinamide and derivatives block ethylene biosynthesis by inhibiting ACC oxidasePyrazinamide resistance in Mycobacterium tuberculosis fails to bite?Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.Antibiotic resistance mechanisms in M. tuberculosis: an update.The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance.Non-canonical transcription initiation: the expanding universe of transcription initiating substrates.Backbone and side-chain resonance assignments for the tmRNA-binding protein, SmpB, from Mycobacterium tuberculosis.(1)H, (15)N, (13)C resonance assignments for pyrazinoic acid binding domain of ribosomal protein S1 from Mycobacterium tuberculosis.Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of associated with pyrazinamide resistanceDesign, Synthesis and Evaluation of -pyrazinylbenzamides as Potential Antimycobacterial AgentsDesign, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold
P2860
Q30243915-72E4439F-8906-4878-AF35-31CF88071B18Q30399431-27E55567-002D-4A1E-B148-7B56B06CF07AQ33804763-E7D7423A-4576-4641-BFFD-7B78E36097D3Q38494436-BAB1E104-010C-4973-8EEC-F74C56CA65FCQ38674445-F79EA6A4-1045-456F-9982-591C270A83A6Q38718136-FD861CD1-BF77-4250-8EE9-6E5E558B92D4Q38830420-41C33525-DC38-49DC-B9FA-4E5A767AAC7FQ47215879-DC876F55-57A8-469E-A673-3A9F16B5ED22Q47632774-94F3733C-A51F-4BDD-BF5C-1B7E0F691DCFQ48113518-4C36B828-3F86-45F7-8A73-0E104B36A0A0Q48331193-B44E2B32-196F-4ED6-A1DF-537CD6489F28Q50556478-DEE9A19B-CA5E-4DEE-83D2-456298599453Q50979449-73F01DF7-CAB9-4AEC-A55C-C8406920026EQ51249912-C3D8CEC9-742D-481E-83BB-A521B91CDD06Q58583416-6DB82999-E529-4C75-914C-E3BBB9056749Q58691665-0F4134C8-37A2-43DD-8F46-AC8E31E2BA91Q59054206-ACE00A3B-7753-47EB-9E80-EA848A3BD2F3
P2860
Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@ast
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@en
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@nl
type
label
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@ast
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@en
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@nl
prefLabel
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@ast
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@en
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@nl
P2093
P2860
P356
P1476
Structural basis for targeting ...... m tuberculosis by pyrazinamide
@en
P2093
Chenyun Guo
Donghai Lin
Honghai Wang
Juanjuan Yang
Qian Zhang
Tianwei Lin
Wenqian Li
Xinli Liao
P2860
P304
P356
10.1111/MMI.12892
P407
P50
P577
2015-03-01T00:00:00Z